Search - tctmd.com

Displaying 381 - 400 of 448

Sort: Relevancy | Date

News Daily News

DCBs Perform Better in De Novo Compared With Restenotic Femoropopliteal Lesions

Caitlin E. Cox

October 24, 2014

Presentation TCT 2014

A Novel Drug-Coated Scoring Balloon for the Treatment of Coronary In-Stent Restenosis: One Year Results of the PATENT-C First-in-Human Trial

Presenter: Bruno Scheller

September 16, 2014

News Industry News

Medtronic Drug-Coated Balloon Shows Strong Clinical and Economic Benefit in Treatment of Peripheral Artery Disease

September 16, 2014

Presentation TCT 2014

DCB Use in the Real World I: In-Stent Restenosis Insights From the FAIR Trial

Presenter: Kenneth Rosenfield, Thomas Zeller, Raghu Kolluri

September 15, 2014

Presentation TCT 2014

TCT 267: Lower Mortality of Paclitaxel-Coated Balloon Compared with Paclitaxel-Eluting Stent for the Treatment of DES In-Stent Restenosis: Two-Year Follow-up of the PEPCAD China ISR Trial

Presenter: Run-Lin Gao, Jochen Wöhrle, Bruno Scheller, Yelin Zhao

September 13, 2014

Presentation TCT 2014

DCB in BMS vs DES ISR: Insights from the RIBS Trials

Presenter: Run-Lin Gao, Jochen Wöhrle, Bruno Scheller, Fernando Alfonso

September 13, 2014

Presentation TCT 2014

Approach to In-Stent Restenosis in 2014: DCB or DES?

Presenter: Run-Lin Gao, Jochen Wöhrle, Bruno Scheller, Robert A. Byrne

September 13, 2014

Presentation TCT 2014

DCB Plus Adjunctive Stenting: Technique and Clinical Results

Presenter: Robert A. Byrne, Bruno Scheller, Francesco Liistro, Jochen Wöhrle

September 13, 2014

Presentation TCT 2014

DCB Only Followed by Provisional Stenting: Insights from BASKET-SMALL 2 Trial

Presenter: Robert A. Byrne, Bruno Scheller, Francesco Liistro, Raban Jeger

September 13, 2014

News Conference News TCT 2014

PEPCAD-DES at 3 Years: Paclitaxel-Coated Balloon Holds Advantage for DES Restenosis

September 13, 2014

News Industry News

Boston Scientific Announces Schedule For Presentations At Upcoming TCT 2014

September 10, 2014

News Industry News

Boston Scientific Receives CE Mark For Agent™ Drug-Coated Balloon

July 23, 2014

News Daily News

Un Panel Asesor de la FDA Aprueba un Balón recubierto de Paclitaxel para el Manejo de la Enfermedad Femoropoplítea

L.A. McKeown

June 17, 2014

News Industry News

Medtronic Submits Final Data to FDA for Novel Device to Treat Peripheral Artery Disease

June 11, 2014

News Industry News

Cook Medical makes Zilver® PTX® drug-eluting stent available in Canada

June 05, 2014

News Daily News

ILLUMENATE First-in-Human Study: Novel Drug-Coated Balloon Yields Strong 2-Year Outcomes in SFA Lesions

May 30, 2014

News Industry News

Biosensors Announces IDE Approval for BioFreedom™ U.S. Trial

May 05, 2014

News Daily News

Drug-Eluting Balloon Provides Strong Primary Patency in SFA at 1 Year

April 14, 2014

Presentation CTO 2014

Left Main Restenosis: Incidence, Implications, and Management

Presenter: Roxana Mehran

March 01, 2014

Presentation CTO 2014

Dedicated Bifurcation Stents in Left Main Disease: Do the Data Support Their Need?

Presenter: Martin B. Leon

March 01, 2014

Advertisement

DCBs Perform Better in De Novo Compared With Restenotic Femoropopliteal Lesions

A Novel Drug-Coated Scoring Balloon for the Treatment of Coronary In-Stent Restenosis: One Year Results of the PATENT-C First-in-Human Trial

Medtronic Drug-Coated Balloon Shows Strong Clinical and Economic Benefit in Treatment of Peripheral Artery Disease

DCB Use in the Real World I: In-Stent Restenosis Insights From the FAIR Trial

TCT 267: Lower Mortality of Paclitaxel-Coated Balloon Compared with Paclitaxel-Eluting Stent for the Treatment of DES In-Stent Restenosis: Two-Year Follow-up of the PEPCAD China ISR Trial

DCB in BMS vs DES ISR: Insights from the RIBS Trials

Approach to In-Stent Restenosis in 2014: DCB or DES?

DCB Plus Adjunctive Stenting: Technique and Clinical Results

DCB Only Followed by Provisional Stenting: Insights from BASKET-SMALL 2 Trial

PEPCAD-DES at 3 Years: Paclitaxel-Coated Balloon Holds Advantage for DES Restenosis

Boston Scientific Announces Schedule For Presentations At Upcoming TCT 2014

Boston Scientific Receives CE Mark For Agent™ Drug-Coated Balloon

Un Panel Asesor de la FDA Aprueba un Balón recubierto de Paclitaxel para el Manejo de la Enfermedad Femoropoplítea

Medtronic Submits Final Data to FDA for Novel Device to Treat Peripheral Artery Disease

Cook Medical makes Zilver® PTX® drug-eluting stent available in Canada

ILLUMENATE First-in-Human Study: Novel Drug-Coated Balloon Yields Strong 2-Year Outcomes in SFA Lesions

Biosensors Announces IDE Approval for BioFreedom™ U.S. Trial

Drug-Eluting Balloon Provides Strong Primary Patency in SFA at 1 Year

Left Main Restenosis: Incidence, Implications, and Management

Dedicated Bifurcation Stents in Left Main Disease: Do the Data Support Their Need?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content